Skip to main content Back to Top

ISMP Targeted Medication Safety Best Practices for Hospitals Goal #17 -Safeguard Against Errors for Oxytocin Use

Broadcast Date: January 11, 2023


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

This episode provides a review of ISMP Best Practice #17 recommendations for safeguards against errors with oxytocin use. Speakers will discuss how to understand the risks involved in oxytocin utilization with antepartum and postpartum management and will describe considerations for implementing such safeguards.


Michelle HolleyMichele Holley, PharmD, MS, is a pharmacist and Medication Safety Officer for Mount Carmel Health System in Columbus, Ohio where she reviews best practices to improve the safety and quality of medication use within the health system. She has supported the Mount Carmel Colleague Vaccination Clinics and reviewed vaccines, monoclonal antibodies, and other therapeutic treatment options for safe patient use. She graduated from Ohio Northern University with a PharmD and The Ohio State University with a Master’s in Health System Pharmacy Administration.

Natalie NguyenNatalie Nguyen, PharmD, MSHA, is the Medication Safety Pharmacy Manager at VCU Health. Nguyen received her PharmD from the Virginia Commonwealth University (VCU) School of Pharmacy in Richmond, VA. She completed a PGY1/PGY2 Health-System Pharmacy Administration and Leadership Residency at VCU Health, and MS in Health Administration at VCU Health and the VCU College of Health Professions. Contributions with ASHP includes serving in the SICP Advisory Group on Medication Safety and House of Delegates.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.